Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prolactin Secreting Adenoma”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableUnknownNCT02536261
What this trial is testing

Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus

Who this might be right for
Invasive Prolactinomas Involving the Cavernous Sinus
Zhebao Wu 30
Not applicableActive Not RecruitingNCT03665064
What this trial is testing

Long Term Outcome Study in Patients With Pituitary Disorders

Who this might be right for
Pituitary DiseasesPituitary Neoplasms
University of Alberta 1,500
Not applicableUnknownNCT03400865
What this trial is testing

Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas

Who this might be right for
Resistance, DiseaseProlactinoma
Zhebao Wu 30
Not applicableUnknownNCT03474601
What this trial is testing

Seoul National University Pituitary Disease Cohort Study

Who this might be right for
Pituitary DiseasePituitary IncidentalomaAcromegaly+5 more
Seoul National University Hospital 1,600
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Not applicableUnknownNCT00598949
What this trial is testing

Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

Who this might be right for
Pituitary Tumor
Cedars-Sinai Medical Center 600
Post-approval studies (Phase 4)Looking for participantsNCT07045935
What this trial is testing

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

Who this might be right for
Prolactinoma
University Hospital, Basel, Switzerland 60
Not applicableStudy completedNCT00460616
What this trial is testing

Cardiac Valve Complications in Prolactinomas Treated With Cabergoline

Who this might be right for
Prolactinomas
Federico II University 50
Not applicableUnknownNCT03717454
What this trial is testing

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Who this might be right for
Prolactinoma
Zhebao Wu 50
Not applicableUnknownNCT01143584
What this trial is testing

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

Who this might be right for
Macroprolactinoma
Post Graduate Institute of Medical Education and Research, Chandigarh 20
Early research (Phase 1)UnknownNCT01344291
What this trial is testing

Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients

Who this might be right for
Hyperprolactinoma
Mashhad University of Medical Sciences 30
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Not applicableUnknownNCT01775332
What this trial is testing

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

Who this might be right for
Pituitary NeoplasmsProlactinomaACTH-Secreting Pituitary Adenoma+2 more
Unity Health Toronto 60
Not applicableLooking for participantsNCT07268183
What this trial is testing

How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors

Who this might be right for
ProlactinomaMacroprolactinoma
Hospices Civils de Lyon 180
Large-scale testing (Phase 3)Study completedNCT01620138
What this trial is testing

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Who this might be right for
Non-functioning Pituitary AdenomasProlactinomas
Universidade Federal do Rio de Janeiro 21
Testing effectiveness (Phase 2)Looking for participantsNCT06295952
What this trial is testing

Pasireotide in People With Prolactinoma

Who this might be right for
Prolactin-Producing Pituitary Tumor
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03038308
What this trial is testing

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Who this might be right for
HyperprolactinemiaProlactinoma
Columbia University 16
Not applicableUnknownNCT03457389
What this trial is testing

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Who this might be right for
Pituitary AdenomaProlactinomaPituitary Tumor+1 more
Seoul National University Hospital 68
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableActive Not RecruitingNCT06936813
What this trial is testing

The PROMISE Survey

Who this might be right for
ProlactinomaPituitary Tumor
University Hospital, Basel, Switzerland 530
Load More Results